188 related articles for article (PubMed ID: 22314267)
21. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.
Chen SQ; Wang PJ; Ten GJ; Zhan W; Li MH; Zang FC
Dement Geriatr Cogn Disord; 2009; 28(6):558-66. PubMed ID: 20093832
[TBL] [Abstract][Full Text] [Related]
22. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
23. Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease.
Mohamed NE; Lee JH; Francis PT; Esiri MM; Chen CP; Lai MK
J Alzheimers Dis; 2015; 44(2):431-7. PubMed ID: 25261450
[TBL] [Abstract][Full Text] [Related]
24. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
25. A neuropsychological profile and its correlation with neuroimaging markers in patients with subcortical ischaemic vascular dementia.
Tian R; Zhang Y; Liu F; Xue X; Zhang Y; Tian Z; Fang T; Fan R; Li Y; Zhang N
Int J Geriatr Psychiatry; 2023 Mar; 38(3):e5900. PubMed ID: 36862560
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
27. Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Jahng GH; Oh J; Lee DW; Kim HG; Rhee HY; Shin W; Paik JW; Lee KM; Park S; Choe BY; Ryu CW
J Alzheimers Dis; 2016 Mar; 52(1):145-59. PubMed ID: 27060946
[TBL] [Abstract][Full Text] [Related]
28. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
29. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
30. Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias.
Sheng Y; Lee JH; Medhurst AD; Wilcock GK; Esiri M; Wong PT; Chen CP; Lai MK
J Neurol Sci; 2012 Apr; 315(1-2):110-4. PubMed ID: 22129936
[TBL] [Abstract][Full Text] [Related]
31. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
Constans JM; Meyerhoff DJ; Gerson J; MacKay S; Norman D; Fein G; Weiner MW
Radiology; 1995 Nov; 197(2):517-23. PubMed ID: 7480705
[TBL] [Abstract][Full Text] [Related]
32. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
[TBL] [Abstract][Full Text] [Related]
33. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
[TBL] [Abstract][Full Text] [Related]
34. Influence of controlled encoding and retrieval facilitation on memory performance of patients with subcortical ischemic vascular dementia and Alzheimer's disease.
Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
J Neurol; 2019 Oct; 266(10):2447-2456. PubMed ID: 31214768
[TBL] [Abstract][Full Text] [Related]
35. Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy.
Herminghaus S; Frölich L; Gorriz C; Pilatus U; Dierks T; Wittsack HJ; Lanfermann H; Maurer K; Zanella FE
Psychiatry Res; 2003 Jul; 123(3):183-90. PubMed ID: 12928106
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Watanabe T; Shiino A; Akiguchi I
Neurobiol Learn Mem; 2012 Mar; 97(3):289-93. PubMed ID: 22390859
[TBL] [Abstract][Full Text] [Related]
37. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.
Gasparovic C; Prestopnik J; Thompson J; Taheri S; Huisa B; Schrader R; Adair JC; Rosenberg GA
J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):715-21. PubMed ID: 23418212
[TBL] [Abstract][Full Text] [Related]
38. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
39. Down syndrome with and without dementia: an in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease.
Lamar M; Foy CML; Beacher F; Daly E; Poppe M; Archer N; Prasher V; Murphy KC; Morris RG; Simmons A; Lovestone S; Murphy DGM
Neuroimage; 2011 Jul; 57(1):63-68. PubMed ID: 21504795
[TBL] [Abstract][Full Text] [Related]
40. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing.
Lind A; Boraxbekk CJ; Petersen ET; Paulson OB; Siebner HR; Marsman A
J Neurosci; 2020 Oct; 40(42):8149-8159. PubMed ID: 32994337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
